NewEdge Wealth LLC bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 36,043 shares of the medical device company’s stock, valued at approximately $2,585,000.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in COO. BlackRock Inc. purchased a new stake in shares of Cooper Companies in the second quarter worth about $1,077,762,000. Generation Investment Management LLP purchased a new position in Cooper Companies during the second quarter valued at approximately $356,304,000. Wellington Management Group LLP lifted its holdings in Cooper Companies by 332.9% in the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock valued at $424,043,000 after acquiring an additional 4,756,178 shares during the period. Diamond Hill Capital Management Inc. boosted its position in Cooper Companies by 479.6% in the 4th quarter. Diamond Hill Capital Management Inc. now owns 3,287,837 shares of the medical device company’s stock worth $269,471,000 after purchasing an additional 2,720,594 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD grew its stake in shares of Cooper Companies by 58.8% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after purchasing an additional 2,231,568 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.
More Cooper Companies News
Here are the key news stories impacting Cooper Companies this week:
- Positive Sentiment: The company’s latest reported quarter showed solid operating performance: adjusted earnings of $1.21 per share exceeded consensus by $0.11, revenue reached $1.08 billion versus expectations of $1.05 billion, and sales increased 7.9% year over year. COO also maintained fiscal 2026 EPS guidance of $4.58–$4.66.
- Neutral Sentiment: Recent headlines mentioning “Cooper,” “COO,” or cooperation—including Bass Oil’s Cooper Basin update, Wendy’s discussion of a chief operating officer role, and Trainline’s regulatory cooperation—do not concern The Cooper Companies and are not relevant catalysts for COO.
- Negative Sentiment: With no fresh corporate catalyst in the provided articles, the modest weakness may reflect normal trading, profit-taking, or valuation concerns. The stock trades at a relatively high price-to-earnings multiple of about 64.5, leaving shares sensitive to changes in investor expectations even after the recent earnings beat.
Wall Street Analysts Forecast Growth
Cooper Companies Trading Down 0.7%
Shares of COO stock opened at $76.16 on Friday. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The company has a market cap of $14.85 billion, a price-to-earnings ratio of 64.54, a PEG ratio of 2.01 and a beta of 0.83. The stock has a 50 day simple moving average of $71.76 and a 200-day simple moving average of $71.12. The Cooper Companies, Inc. has a 1-year low of $58.89 and a 1-year high of $89.83.
Cooper Companies (NASDAQ:COO – Get Free Report) last announced its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. During the same quarter last year, the firm posted $0.96 EPS. The business’s revenue was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, equities research analysts expect that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.
Cooper Companies Profile
Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.
The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.
Featured Articles
- Five stocks we like better than Cooper Companies
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO – Free Report).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.
